Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Neuromyelitis optica in children. Two case reports.]
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Tetracyclines inhibit human synovial collagenase in vivo and in vitro.
Neuroinflammation: The role and consequences.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
So many progenitors, so little myelin.
Multiple sclerosis susceptibility alleles in African Americans.
Exome sequencing to find rare variants causing neurologic diseases.
Personalized medicine in multiple sclerosis: hope or reality?
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Modulators of Microglia: a Patent Review.
Exercise, brain, and cognition across the life span.
Data supporting Arf6 regulation of Schwann cell differentiation and myelination.
Resistance training and vibration improve muscle strength and functional capacity in female patients with multiple sclerosis.
Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Spasticity in multiple sclerosis: results of a patient survey.
[2012: news in neurology].
Pages
« first
‹ previous
…
270
271
272
273
274
275
276
277
278
…
next ›
last »